News
 

Treatment with hookworm larvae was well tolerated in patients with multiple sclerosis (MS), and although the primary outcome was not met there was some evidence of a beneficial therapeutic effect in the first randomized clinical trial to evaluate such an approach.

Neurofilament light (NfL) and microRNAs (miRNAs) can help to predict the course that multiple sclerosis (MS) will take for individuals, according to two new studies published in Neurology and Acta Neurologica Scandinavica. The markers could help to identify progressive disease and facilitate treatment decisions.

A new analysis shows that rates of intracerebral hemorrhage (ICH) have not fallen during recent years, as has been seen with ischemic stroke, and rates appear to be increasing in the elderly.

A vegetarian diet rich in nuts, vegetables, and soy has been linked to a lower risk of both ischemic and hemorrhagic stroke, new research suggests.

Despite the ever-increasing acceptance of medical cannabis and its notably common use in patients with multiple sclerosis (MS), clinicians treating those patients still may be poorly informed about risks, benefits, regulations, and proper uses, experts say.

Neurologic effects can be a significant part of COVID-19, but does the SARS-CoV-2 virus directly damage the central nervous system or are the neurologic symptoms attributable to secondary mechanisms?